跳至主要内容
临床试验/EUCTR2021-002551-11-DK
EUCTR2021-002551-11-DK进行中(未招募)1 期

Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI

Aarhus University0 个研究点目标入组 30 人开始时间: 2021年5月27日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All participants:
  • -Aged 18 – 85 years.
  • -Pre-menopausal women must be confirmed non-pregnant by an onsite test.
  • PKD group:
  • -Autosomal dominant polycystic kidney disease.
  • -CKD for any reason except PKD.
  • -Recent biopsy (within 3 months of MRI).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 22
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 8

排除标准

  • Contraindications for MRI with contrast:
  • -eGFR less than 30 ml/min/1.73m2
  • -Significant cardiac disease such as severe left ventricular outflow obstruction
  • -Significant obstructive lung disease or severe asthma
  • -Pacemaker, neurostimulator or cholera implant
  • -Metal foreign bodies such as fragments and irremovable piercings
  • -Unsafe medical implants (safety of heart valves, hips and the like must be confirmed)
  • -Claustrophobia
  • -Largest circumference including arms > 160 cm
  • Competing renal or systemic disease (except unspecific renal MRI findings, hypertension, atherosclerosis, well-regulated diabetes and hyperlipidemia/cholesterolemia which are allowed)
  • Renovascular disease
  • Allergy to pyruvate

研究者

相似试验